 effect enoximone dobutamine hemodynamic performance open heart surgery clinical comparison prospective study phosphodiesterase inhibitor enoximone open heart surgery group patients enoximone dobutamine cardiopulmonary bypass hours drug continuous infusion micrograms/min/kg body weight enoximone significant increase cardiac output enoximone dobutamine significant decrease pulmonary vascular resistance total systemic vascular resistance Systemic blood pressure heart rate different Side effects safe superior low cardiac output states open heart surgery